Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-467-99.
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #: a) 7801082, Exp. 07/15 and b) 7801421, Exp. 09/16
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Mylan Institutional LLC
- Reason for Recall:
- Presence of Particulate Matter
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-467-99.
Product Codes/Lot Numbers:
Lot #: a) 7801082, Exp. 07/15 and b) 7801421, Exp. 09/16
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-1328-2015
Related Recalls
Super-Potent Drug: Out of specification potency results were obtained.
Super-Potent Drug: Out of specification potency results were obtained.
Subpotent and Superpotent Drug